PDF(Pubmed)
Abstract：
This study evaluated an oscillometric device (OD), Microlife WatchBP Office AFIB, and a hybrid manual auscultatory device (AD), Greenlight 300TM, to determine a suitable blood pressure (BP) measurement device for the Korea National Health and Nutrition Examination Survey in a mercury-free context. Adhering to the 2018 Universal Standard\'s suggested consensus, the study involved 800 subjects (mean age 51.2 ± 17.5 years; 44.3% male), who underwent triplicate BP measurements following 5 min of rest in a randomized order (OD-first: 398 participants; AD-first: 402 participants). BP difference was calculated as OD value minus AD value, with results stratified by measurement sequence. The overall BP difference and tolerable error probability were -1.1 ± 6.5/-2.6 ± 4.9 mmHg and 89.2%/92.5% for systolic/diastolic BP (SBP/DBP), respectively. Lin\'s concordance correlation coefficient was 0.907/0.844 for SBP/DBP (OD-first/AD-first: 0.925/0.892 for SBP, 0.842/0.845 for DBP). The overall agreement for hypertension (BP ≥ 140 and/or 90 mmHg) was 0.71 (p < 0.0001), and the OD underestimated the overall hypertension prevalence by 5.1%. Analysis of the AD-first data revealed a lower level of agreement compared to the OD-first data; however, the observed blood pressure difference adhered to Criterion 1 of the 2018 Universal Standard. Microlife met the Criterion 1 of 2018 Universal Standard but underestimated the prevalence of hypertension. The BP discrepancy increased with higher BP levels, male sex, and smaller AC. With increasing age, the discrepancy decreased for SBP and increased for DBP.
摘要：
这项研究评估了示波装置(OD)，MicrolifeWatchBP办公室AFIB，和混合手动听诊装置（AD），Greenlight300TM,在无汞的情况下，为韩国国家健康和营养检查调查确定合适的血压（BP）测量设备。坚持2018年通用标准的建议共识，该研究涉及800名受试者（平均年龄51.2±17.5岁；44.3%为男性），按随机顺序休息5分钟后，进行了一式三份的BP测量（OD-优先：398名参与者；AD-优先：402名参与者）。BP差值计算为OD值减去AD值，结果按测量顺序分层。收缩压/舒张压（SBP/DBP）的总体BP差异和可容忍误差概率分别为-1.1±6.5/-2.6±4.9mmHg和89.2％/92.5％，分别。SBP/DBP的Lin一致相关系数为0.907/0.844(OD-first/AD-first:0.925/0.892,0.842/0.845对于DBP)。高血压（BP≥140和/或90mmHg）的总体一致性为0.71（p<0.0001），OD低估了整体高血压患病率5.1%。对AD-first数据的分析显示，与OD-first数据相比，一致性较低；但是，观察到的血压差符合2018年通用标准的标准1.微生命符合2018年通用标准的标准1，但低估了高血压的患病率。BP差异随着BP水平的提高而增加，男性,更小的AC。随着年龄的增长,SBP的差异减少，DBP的差异增加。
